H. Brevinge

发表

Relationships between self-reported health related quality of life and measures of standardized exercise capacity and metabolic efficiency in a middle-aged and aged healthy population

K. Lundholm, E. Lindholm, H. Brevinge, 2003, Quality of Life Research.

The Yield of Flexible Sigmoidoscopy and Double-Contrast Barium Enema in the Diagnosis of Neoplasms in the Large Bowel in Patients with a Positive Hemoccult Test

E. Haglind, J. Kewenter, H. Brevinge, 1995, Endoscopy.

Endoscopic and surgical complications of work-up in screening for colorectal cancer

J. Kewenter, H. Brevinge, 1996, Diseases of the colon and rectum.

Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55 – 56 years' old population

J. Kewenter, E. Lindholm, H. Brevinge, 1997, International Journal of Colorectal Disease.

Induction and Distribution of Intestinal Immune Responses after Administration of Recombinant Cholera Toxin B Subunit in the Ileal Pouches of Colectomized Patients

A. Svennerholm, M. Quiding-Järbrink, H. Brevinge, 2001, Infection and Immunity.

Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl‐Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL‐60 leukocyte adhesion to E‐selectin‐expressing endothelial cells

G. Hansson, H. Brevinge, D. Baeckström, 1996, Journal of cellular biochemistry.

Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion.

G. Hansson, H. Brevinge, D. Baeckström, 1997, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Total exchangeable sodium related to body composition in patients with conventional or reservoir ileostomy.

L. Jacobsson, H. Brevinge, 1994, Scandinavian journal of gastroenterology.

The effect of recombinant human IGF‐I on protein metabolism in post‐operative patients without nutrition compared to effects in experimental animals

E. Haglind, C. Ohlsson, H. Zachrisson, 1995, European journal of clinical investigation.

Cancer Immunity (29 February 2008) Vol. 8, p. 5

S. Nordgren, M. Andersson, C. Lönnroth, 2005 .

Role of prostaglandins in colorectal tumorigenesis: Localization and expression of COX-1, COX-2, microsomal Prostaglandin E Synthase-1 and the EP2 receptor

F. Pontén, K. Sundfeldt, L. Hedin, 2013 .

P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection

K. Lundholm, H. Remotti, M. Andersson, 2001, Cancer.

T- and B-Cell Immune Responses of Patients Who Had Undergone Colectomies to Oral Administration of Salmonella enterica Serovar Typhi Ty21a Vaccine

S. Lundin, A. Svennerholm, H. Brevinge, 2003, Clinical Diagnostic Laboratory Immunology.

Ileostomy output of gas and feces before and after conversion from conventional to reservoir ileostomy

H. Brevinge, N. Kock, B. Berglund, 1992, Diseases of the colon and rectum.

The place for colectomy and ileorectal anastomosis: a valid surgical option for ulcerative colitis?

L. Hultén, H. Brevinge, T. Öresland, 2006, Techniques in Coloproctology.

Continent ileostomy. The present technique and long term results.

H. Brevinge, N. Kock, B. Philipson, 1986, Annales chirurgiae et gynaecologiae.

Immune Responses in Ileostomy Fluid and Serum after Oral Cholera Vaccination of Patients Colectomized because of Ulcerative Colitis

A. Svennerholm, H. Brevinge, M. Jertborn, 1998, Infection and Immunity.

Total body water and total body potassium in ileostomy patients before and after conversion to the continent ileostomy.

I. Bosaeus, L. Nilsson, H. Brevinge, 1988, Gut.

Sodium and potassium excretion before and after conversion from conventional to reservoir ileostomy

I. Bosaeus, J. Kewenter, H. Brevinge, 1992, International Journal of Colorectal Disease.

Altered erythrocyte transmembrane transport of sodium and potassium in patients with conventional or reservoir ileostomy.

H. Herlitz, H. Brevinge, O. Jonsson, 1993, Scandinavian journal of clinical and laboratory investigation.

Neoplasia in the colorectal specimens of patients with ulcerative colitis and ileal pouch-anal anastomosis – need for routine surveillance?

R. Willén, E. Lindholm, H. Brevinge, 2015, Scandinavian journal of gastroenterology.

Follow-up after screening for colorectal neoplasms with fecal occult blood testing in a controlled trial

E. Haglind, J. Kewenter, H. Brevinge, 1994, Diseases of the colon and rectum.

Bladder substitutes controlled by the anal sphincter: a comparison of the different absorption potentials.

M. Ghoneim, H. Brevinge, N. Kock, 1991, The Journal of urology.

Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.

I. Bosaeus, K. Lundholm, P. Daneryd, 1998, Cancer research.

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer

E. Haglind, E. Lindholm, H. Brevinge, 2008, The British journal of surgery.

Exercise capacity in patients undergoing proctocolectomy and small bowel resection for Crohn's disease

I. Bosaeus, K. Lundholm, B. Berglund, 1995, The British journal of surgery.

Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma.

K. Lundholm, M. Andersson, C. Lönnroth, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer.

K. Lundholm, S. Nordgren, M. Andersson, 2008, Cancer immunity.

American Society of Colon and Rectal Surgeons 91st Annual Convention Podium and Poster abstracts

P. M. Falk, L. K. Harding, T. G. Perry, 1992 .

Patients following Treatment with Recombinant Erythropoietin: A Randomized Prospective Study1

I. Bosaeus, K. Lundholm, P. Daneryd, 2014 .

Genotypic Variation in the Bordetella pertussis Virulence Factors Pertactin and Pertussis Toxin in Historical and Recent Clinical Isolates in the United Kingdom

A. Svennerholm, H. Brevinge, M. Jertborn, 2001 .

Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.

E. Haglind, J. Kewenter, H. Brevinge, 1994, Scandinavian journal of gastroenterology.